William J. Woltjen

William J. Woltjen serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions within a specialized federal acquisition environment. He ensures compliance with federal regulations, including the FAR and agency-specific policies, while executing competitive and non-competitive acquisitions for critical medical diagnostic products. His role centers on translating technical requirements into enforceable contract terms, conducting market research, and ensuring alignment with mission-critical public health objectives. Woltjen typically handles complex, high-stakes procurements involving in-vitro diagnostic substances, requiring deep technical understanding and precise contract administration to support laboratory and clinical testing infrastructure. Woltjen’s contractor relationships are primarily with manufacturers and suppliers specializing in diagnostic reagents, assay kits, and related laboratory consumables. While no single vendor dominates his portfolio, he engages with a broad spectrum of qualified industry participants, including mid-sized biomedical firms and niche innovators with FDA-registered manufacturing capabilities. His procurement approach emphasizes transparency, fair competition, and rigorous source selection under FAR Part 15, fostering consistent vendor engagement through clear solicitation language and timely communication. Woltjen’s contracting patterns reflect a strong preference for open competition, with 100% of his acquisitions conducted without set-aside designations. This indicates a focus on technical merit and supply chain reliability over socioeconomic categorizations, though he remains fully compliant with all small business participation goals. His approach prioritizes access to the broadest possible pool of qualified vendors to ensure uninterrupted availability of essential diagnostic products. His primary area of expertise lies in NAICS 325413—In-Vitro Diagnostic Substance Manufacturing—where he procures reagents, calibrators, control materials, and associated diagnostic systems used in clinical and public health laboratories. Woltjen possesses specialized knowledge of regulatory standards such as CLIA and ISO 13485, ensuring acquired products meet stringent quality and performance benchmarks for diagnostic accuracy and patient safety.